The controlling shareholder of Guangdong Ellington Electronics Technology (603328.SH) plans to increase its holdings of the company's shares by 1% to 2%.

17:01 07/08/2026

Idun Electronics (603328.SH) announced that on August 7, 2026, the company received a notice from its controlling shareholder, Jiuzhou Group, regarding the "Share Increase Plan." Based on confidence in the company's future sustainable and stable development and recognition of the company's long-term investment value, Jiuzhou Group intends to increase its shareholding in the company through a centralized competitive bidding method via the Shanghai Stock Exchange system within three months from the date of the announcement, planning to cumulatively increase its stake by no less than 1% and no more than 2% of the company's total share capital.

Guangdong Ellington Electronics Technology (603328.SH) announced that on August 7, 2026, it received a notice from its controlling shareholder, Harbin Jiuzhou Group, regarding a share increase plan. Based on confidence in the company's future sustainable development and recognition of its long-term investment value, Harbin Jiuzhou Group intends to increase its shareholding in the company through the Shanghai Stock Exchange system in a centralized bidding manner within three months from the date of announcement, with a planned total increase of shares not less than 1% of the company's total equity but not exceeding 2% of the total equity.

Sealand: Air passenger transport is expected to stabilize and recover, and industry profitability may welcome improvement.

HK Stock Market Move | GENFLEET-B (02595) rose nearly 4% as GFH375 entered a Phase III clinical trial for the registration of monotherapy for non-small cell lung cancer in China.

HK Stock Market Move | WESTCHINACEMENT (02233) rose more than 10% during the session, expecting a net profit of up to 412 million yuan in the first half of the year, with overseas earnings growing against the trend.

Sealand: Air passenger transport is expected to stabilize and recover, and industry profitability may welcome improvement.

HK Stock Market Move | GENFLEET-B (02595) rose nearly 4% as GFH375 entered a Phase III clinical trial for the registration of monotherapy for non-small cell lung cancer in China.